American Century Companies
MYOK

American Century Companies’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

American Century Companies’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-97,918
Closed -$13.3M – 2060
2020
Q3 		$13.3M Buy
97,918
+1,196
+1% +$127K 0.01% 640
2020
Q2 		$9.35M Buy
96,722
+241
+0.2% +$20.1K 0.01% 690
2020
Q1 		$4.52M Sell
96,481
-10,810
-10% -$693K 0.01% 739
2019
Q4 		$7.82M Buy
107,291
+16,680
+18% +$1.01M 0.01% 734
2019
Q3 		$4.72M Buy
+90,611
New +$4.82M ﹤0.01% 816

American Century Companies's MYOK Position: Q4 2020 in Review

American Century Companies sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 97,918 shares — an estimated $13.3M sold.

American Century Companies first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $13.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • American Century Companies reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • American Century Companies sold 97,918 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $13.3M.
  • American Century Companies first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • American Century Companies's MyoKardia, Inc. Common Stock position peaked at $13.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.